217 related articles for article (PubMed ID: 11165993)
1. Management of nonsteroidal anti-inflammatory drug-related peptic ulcer bleeding.
Sung JJ
Am J Med; 2001 Jan; 110(1A):29S-32S. PubMed ID: 11165993
[TBL] [Abstract][Full Text] [Related]
2. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Graham DY
Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
[TBL] [Abstract][Full Text] [Related]
4. Management of NSAID-associated peptic ulcer disease.
Melcarne L; García-Iglesias P; Calvet X
Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):723-33. PubMed ID: 26775657
[TBL] [Abstract][Full Text] [Related]
5. Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study.
Yilmaz S; Bayan K; Dursun M; Canoruç F; Kilinç N; Tüzün Y; Daniş R; Ertem M
Dig Dis Sci; 2007 Jan; 52(1):110-8. PubMed ID: 17151802
[TBL] [Abstract][Full Text] [Related]
6. [HP eradication prevents recurrent hemorrhages caused by acetylsalicylic acid].
Labenz J
MMW Fortschr Med; 2013 Jun; 155(12):31. PubMed ID: 23923307
[No Abstract] [Full Text] [Related]
7. NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management.
Chan FK
Drug Saf; 2005; 28(4):287-300. PubMed ID: 15783239
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors.
Venerito M; Schneider C; Costanzo R; Breja R; Röhl FW; Malfertheiner P
Aliment Pharmacol Ther; 2018 Jun; 47(11):1464-1471. PubMed ID: 29655196
[TBL] [Abstract][Full Text] [Related]
9. Bleeding peptic ulcer in the elderly: risk factors and prevention strategies.
Zullo A; Hassan C; Campo SM; Morini S
Drugs Aging; 2007; 24(10):815-28. PubMed ID: 17896831
[TBL] [Abstract][Full Text] [Related]
10. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
11. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori and nonsteroidal anti-inflammatory drug interactions in bleeding ulcers.
Radaelli F; Minoli G
Gastrointest Endosc; 2002 Oct; 56(4):604-6; discussion 606-7. PubMed ID: 12375565
[No Abstract] [Full Text] [Related]
13. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
Chan FK
Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
[TBL] [Abstract][Full Text] [Related]
14. Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing.
Hunt RH; Bazzoli F
Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():9-16. PubMed ID: 14725573
[TBL] [Abstract][Full Text] [Related]
15. [Guidelines of prevention and treatment for NSAID-related peptic ulcers].
Lee JH; Lee YC; Jeon SW; Kim JW; Lee SW; ;
Korean J Gastroenterol; 2009 Nov; 54(5):309-17. PubMed ID: 19934612
[TBL] [Abstract][Full Text] [Related]
16. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.
Gisbert JP; Khorrami S; Carballo F; Calvet X; Gené E; Dominguez-Muñoz JE
Cochrane Database Syst Rev; 2003; (4):CD004062. PubMed ID: 14584003
[TBL] [Abstract][Full Text] [Related]
17. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
18. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
[TBL] [Abstract][Full Text] [Related]
19. Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users.
Sostres C; Carrera-Lasfuentes P; Benito R; Roncales P; Arruebo M; Arroyo MT; Bujanda L; García-Rodríguez LA; Lanas A
Am J Gastroenterol; 2015 May; 110(5):684-9. PubMed ID: 25895518
[TBL] [Abstract][Full Text] [Related]
20. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study.
Nagata N; Niikura R; Sekine K; Sakurai T; Shimbo T; Kishida Y; Tanaka S; Aoki T; Okubo H; Watanabe K; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
J Gastroenterol Hepatol; 2015 Feb; 30(2):292-8. PubMed ID: 25339607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
